Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 15/20 | 0.68 |
| ▸ | F2 | P00734 | 3/20 | 0.48 |
| ▸ | CCR2 | P41597 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 3/20 | 0.45 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.44 |
| ▸ | KLK1 | P06870 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL6437108 | 0.90 | F10 (0.56) | F10F2CCR2CNR1KLKB1 | |
| Iodide SCHEMBL6432760 | 0.90 | F10 (0.66) | F10F2CCR2CNR1KLKB1 | |
| Iodide SCHEMBL6433240 | 0.89 | F10 (0.65) | F10F2CCR2CNR1 | |
| Bromide SCHEMBL6434471 | 0.89 | F10 (0.68) | F10F2CCR2CNR1KLKB1 | |
| SCHEMBL6438708 | 0.83 | F10 (0.66) | F10F2CCR2CNR1KLKB1 | |
| Acetic Acid SCHEMBL6436733 | 0.83 | F10 (0.91) | F10F2 | |
| SCHEMBL6434800 | 0.82 | CCR2 (0.53) | F10F2CCR2CNR1KLKB1 | |
| Acetic Acid SCHEMBL6436732 | 0.82 | F10 (0.88) | F10F2 | |
| SCHEMBL6436735 | 0.82 | F10 (0.83) | F10F2 | |
| Iodide SCHEMBL6433189 | 0.79 | F10 (0.64) | F10F2CCR2CNR1KLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1042287-B1 | INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA | AVENTIS PHARMA GMBH (DE) | 2005-04-20 | — | — | EP | disclosed |
| US-6337344-B1 | ANTICOAGULANTS AND ENZYME INHIBITORS FOR CARDIOVASCULAR DISORDERS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-01-08 | — | — | US | disclosed |
| EP-1042287-A1 | INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA | Aventis Pharma Deutschland GmbH (DE) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999033800-A1 | INDOLE DERIVATIVES AS INHIBITORS OR FACTOR XA | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 1999-07-08 | — | — | WO | disclosed |